advisorsecurities master

AARDAardvark Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11167
Ticker
AARD
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2025-02-13
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
AARD

Detail

Enriched 2026-08-14 20:47

Market cap
$143,783,438.22
Shares outstanding (class)
21,884,158
Shares outstanding (weighted)
21,884,846
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
28
Location
SAN DIEGO, CA
Description

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data